Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
US FDA Observation
|
Turnaround Potential
1300.8000
-15.90
(
-1.21
%)
NSE
Sep 15, 2025
15:31 PM
27.53% Gain from 52W Low
Volume:
1.3M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
31 Oct 2022
US FDA Observation
1300.80
-1.21%
DR REDDY'S LABS
Buy:
Dr. Reddy's Laboratories Ltd.
by
Prabhudas Lilladhar
Target: 4900
Target
Prabhudas Lilladhar
Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 11 Sep, 2025.
More from Dr. Reddy's Laboratories Ltd.
Recommended
IPO market buzz: Five new issues, eleven listings this week
|
15 Sep 2025, 04:32PM
Market closes lower, Tata Tech to buy Germany-based ES-Tec Group for €75 million
Trendlyne Marketwatch |
15 Sep 2025, 04:03PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021